These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 21789890

  • 1. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH, Liu J, Wang Y, Ali U, Wang T, Chen L.
    Chin J Physiol; 2011 Apr 30; 54(2):96-104. PubMed ID: 21789890
    [Abstract] [Full Text] [Related]

  • 2. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
    Chen L, Zhang QJ, Liu J, Wang S, Ali U, Gui ZH, Wang Y.
    Brain Res; 2009 Aug 25; 1286():192-200. PubMed ID: 19545547
    [Abstract] [Full Text] [Related]

  • 3. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.
    Zhang QJ, Wang S, Liu J, Ali U, Gui ZH, Wu ZH, Hui YP, Wang Y, Chen L.
    Brain Res; 2010 Feb 02; 1312():127-37. PubMed ID: 19948151
    [Abstract] [Full Text] [Related]

  • 4. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M, Date I, Tomita S, Ohmoto T.
    Neurosci Res; 2000 Apr 02; 36(4):319-25. PubMed ID: 10771110
    [Abstract] [Full Text] [Related]

  • 5. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
    Bilbao G, Ruiz-Ortega JA, Miguens N, Ulibarri I, Linazasoro G, Gómez-Urquijo S, Garibi J, Ugedo L.
    Brain Res; 2006 Apr 21; 1084(1):175-84. PubMed ID: 16574080
    [Abstract] [Full Text] [Related]

  • 6. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y, Zhang QJ, Liu J, Ali U, Gui ZH, Hui YP, Chen L, Wu ZH, Li Q.
    Brain Res; 2010 Jan 15; 1310():189-99. PubMed ID: 19896932
    [Abstract] [Full Text] [Related]

  • 7. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H, Jia L, Chen X, Shi L, Xie J.
    Brain Res Bull; 2018 Mar 15; 137():132-139. PubMed ID: 29174294
    [Abstract] [Full Text] [Related]

  • 8. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
    Howells FM, Russell VA, Mabandla MV, Kellaway LA.
    Behav Brain Res; 2005 Dec 07; 165(2):210-20. PubMed ID: 16159673
    [Abstract] [Full Text] [Related]

  • 9. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP, Minabe Y, Middlemiss DN, Shirayama Y, Hashimoto K, Ashby CR.
    Synapse; 2002 Dec 01; 46(3):129-39. PubMed ID: 12325040
    [Abstract] [Full Text] [Related]

  • 10. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.
    Bouali-Benazzouz R, Tai CH, Chetrit J, Benazzouz A.
    Neuroscience; 2009 Dec 01; 164(2):588-96. PubMed ID: 19628021
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
    Sun BC, Jin GZ.
    Biol Signals; 1992 Dec 01; 1(6):331-8. PubMed ID: 1307933
    [Abstract] [Full Text] [Related]

  • 12. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB, Sørensen JCH, Ettrup KS, Orlowski D, Bjarkam CR.
    Brain Res Bull; 2018 May 01; 139():167-173. PubMed ID: 29462643
    [Abstract] [Full Text] [Related]

  • 13. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
    Silva C, Fuxe K, Chadi G.
    J Neural Transm Suppl; 2009 May 01; (73):185-202. PubMed ID: 20411778
    [Abstract] [Full Text] [Related]

  • 14. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
    Lin L, Yan M, Wu B, Lin R, Zheng Z.
    Brain Res Bull; 2018 Sep 01; 142():338-343. PubMed ID: 30172737
    [Abstract] [Full Text] [Related]

  • 15. The theta-related firing activity of parvalbumin-positive neurons in the medial septum-diagonal band of Broca complex and their response to 5-HT1A receptor stimulation in a rat model of Parkinson's disease.
    Li LB, Han LN, Zhang QJ, Sun YN, Wang Y, Feng J, Zhang L, Wang T, Chen L, Liu J.
    Hippocampus; 2014 Mar 01; 24(3):326-40. PubMed ID: 24174292
    [Abstract] [Full Text] [Related]

  • 16. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
    Minabe Y, Emori K, Toor A, Stutzmann GE, Ashby CR.
    Synapse; 1996 Jan 01; 22(1):35-45. PubMed ID: 8822476
    [Abstract] [Full Text] [Related]

  • 17. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C, Kirik D, Devaux B, Moffat B, Phillips HS, Björklund A.
    Eur J Neurosci; 1999 May 01; 11(5):1554-66. PubMed ID: 10215908
    [Abstract] [Full Text] [Related]

  • 18. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N.
    Brain Res; 2016 Sep 01; 1646():354-365. PubMed ID: 27233809
    [Abstract] [Full Text] [Related]

  • 19. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.
    Grünblatt E, Mandel S, Maor G, Youdim MB.
    J Neurochem; 2001 Apr 01; 77(1):146-56. PubMed ID: 11279270
    [Abstract] [Full Text] [Related]

  • 20. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May 01; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.